Targeted therapy with bevacizumab and erlotinib tailored to the molecular profile of patients with recurrent glioblastoma. Preliminary experience

Overview of attention for article published in Acta Neurochirurgica, November 2012

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 62 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 363 followers.

[VEGF] Targeted therapy with bevacizumab and erlotinib tailored to the molecular profile of patients with rec... http://t.co/rOhx1trG PM

Reply Repost Favourite